Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Murat Araz; Mustafa Karaagac; Levent Korkmaz; Lokman Koral; Fatih Inci; Ismail Beypinar; Mukremin Uysal; Mehmet Artac

doi:10.1007/s00280-019-03831-4

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-019-03831-4 ◽

2019 ◽

Vol 83 (6) ◽

pp. 1091-1097 ◽

Cited By ~ 1

Author(s):

Murat Araz ◽

Mustafa Karaagac ◽

Levent Korkmaz ◽

Lokman Koral ◽

Fatih Inci ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Emetogenic Chemotherapy ◽

Antiemetic Therapy ◽

Breast Cancer Patients

Download Full-text

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study

Annals of Oncology ◽

10.1093/annonc/mdy300.106 ◽

2018 ◽

Vol 29 ◽

pp. viii636

Author(s):

M. Araz ◽

M. Karaağaç ◽

L. Korkmaz ◽

L. Koral ◽

F. İnci ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Emetogenic Chemotherapy ◽

Antiemetic Therapy ◽

Breast Cancer Patients

Download Full-text

Abstract P5-11-03: Difference between 1stand 2ndgeneration serotonin receptor antagonists in triplet antiemetic therapy for highly emetogenic chemotherapy in breast cancer patients – according to recent multi-institutional double-blind randomized clinical research on the AC regimen

10.1158/1538-7445.sabcs16-p5-11-03 ◽

2017 ◽

Author(s):

H Ogata ◽

M Saito ◽

M Tsuneizumi ◽

G Kutomi ◽

K Hosoya ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Research ◽

Cancer Patients ◽

Serotonin Receptor ◽

Emetogenic Chemotherapy ◽

Antiemetic Therapy ◽

Breast Cancer Patients ◽

Highly Emetogenic Chemotherapy ◽

Double Blind ◽

Serotonin Receptor Antagonists

Download Full-text

T-DM1 EFFICACY AND ACTIVITY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PROGRESSING AFTER FRONTLINE TAXANE PLUS PERTUZUMAB AND TRASTUZUMAB: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY OF THE GRUPPO ITALIANO MAMMELLA (GIM) STUDY GROUP

The Breast ◽

10.1016/s0960-9776(19)30674-5 ◽

2019 ◽

Vol 48 ◽

pp. S45

Author(s):

Benedetta Conte ◽

Alessandra Fabi ◽

Francesca Poggio ◽

Eva Blondeaux ◽

Chiara Dellepiane ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Study Group ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Multicenter Observational Study

Download Full-text

Metabolic syndrome in breast cancer patients: An observational study

Annals of Oncology ◽

10.1093/annonc/mdy304.019 ◽

2018 ◽

Vol 29 ◽

pp. viii676

Author(s):

S. Khare

Keyword(s):

Breast Cancer ◽

Metabolic Syndrome ◽

Observational Study ◽

Cancer Patients ◽

Breast Cancer Patients

Download Full-text

A pooled analysis of adding olanzapine to guideline-recommended antiemetic therapy for breast cancer patients treated with an anthracycline and cyclophosphamide in prospective and retrospective studies

Supportive Care in Cancer ◽

10.1007/s00520-021-06689-6 ◽

2021 ◽

Author(s):

Bo-Ya Xiao ◽

Tong Su ◽

Yu-Jia Huang ◽

Guo-He Lin ◽

Zhao-Bo Liu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Retrospective Studies ◽

Pooled Analysis ◽

Antiemetic Therapy ◽

Breast Cancer Patients

Download Full-text

Abstract PS9-20: Prospective observational study of chemotherapy-induced alopecia after sequential FEC+taxane and the effects of age in breast cancer patients

10.1158/1538-7445.sabcs20-ps9-20 ◽

2021 ◽

Author(s):

Takaaki Fujii ◽

Kei Ichiba ◽

Chikako Honda ◽

Yuko Nakazawa ◽

Misato Ogino ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Prospective Observational Study ◽

Breast Cancer Patients

Download Full-text

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s12955 ◽

2011 ◽

pp. 151 ◽

Cited By ~ 2

Author(s):

Winnie Yeo ◽

Chan

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Nausea And Vomiting ◽

Antiemetic Therapy ◽

Breast Cancer Patients ◽

Therapy Options

Download Full-text

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

Future Oncology ◽

10.2217/fon.15.34 ◽

2015 ◽

Vol 11 (10) ◽

pp. 1493-1500 ◽

Cited By ~ 5

Author(s):

G Mustacchi ◽

F Puglisi ◽

AM Molino ◽

D Crivellari ◽

C Ghiotto ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab

Download Full-text

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.347 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

C. Molinelli ◽

L. Del Mastro ◽

S. Giraudi ◽

A. Ballestrero ◽

F. Carli ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Cardiac Safety ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Reversibility of trastuzumab induced cardiotoxicity in breast cancer patients: A prospective observational study

Archives of Cardiovascular Diseases Supplements ◽

10.1016/j.acvdsp.2019.09.086 ◽

2020 ◽

Vol 12 (1) ◽

pp. 42

Author(s):

I. Krikez ◽

R. Benmalek ◽

G. Bennouna ◽

A. Drighil ◽

L. Azzouzi ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Prospective Observational Study ◽

Breast Cancer Patients

Download Full-text